“Comment on ‘Apixaban vs. aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischemic attack: subgroup analysis of the ARTESiA randomized controlled trial’”, Bleeding Thromb Vascul Biol, vol. 4, no. 2, Apr. 2025, doi: 10.4081/btvb.2025.179.